Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check5 days agoChange DetectedThe Indian site entries 122001 and 122002 changed from Gurgaon to Gūrgaon (diacritic included); this is a spelling/diacritic update to the same locations.SummaryDifference0.1%

- Check13 days agoChange DetectedStandardized the city name from Gūrgaon to Gurgaon for two Indian sites (122001 and 122002) in the locations section.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedGurgaon location entries were updated to the diacritic form 'Gūrgaon' (two entries). The page revision tag changed from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a glossary and a new 'Last Update Submitted that Met QC Criteria' field; updated the FEAR Act label to 'No FEAR Act Data' and revised the version from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor metadata change that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.